/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

DBV Technologies S.A. - Spons-ADR Share Price Today: Live Updates & Key Insights

DBV Technologies S.A. - Spons-ADR share price today is $19, up -1.85%. The stock opened at $19.7 against the previous close of $19.45, with an intraday high of $19.91 and low of $18.94.

DBV Technologies S.A. - Spons-ADR Share Price Chart

style
pb-0

DBV Technologies S.A. - Spons-ADR

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

DBV Technologies S.A. - Spons-ADR Share Price Performance

$19 -0.0185(-1.85%) DBVT at 23 Mar 2026 12:39 PM Biotechnology
Lowest Today 18.94
Highest Today 19.91
Today’s Open 19.7
Prev. Close 19.45
52 Week High 26.19
52 Week Low 3.91
Day’s Range: Low 18.94 High 19.91
52-Week Range: Low 3.91 High 26.19
1 day return -
1 Week return -6.46
1 month return -10.72
3 month return -6.23
6 month return +95.86
1 year return +286.53
3 year return +477.43
5 year return +71.86
10 year return -

DBV Technologies S.A. - Spons-ADR Institutional Holdings

Artisan Partners Limited Partnership 5.95

Vivo Capital, LLC 4.42

Artisan International Small-Mid Investor 3.64

Artisan Non-U.S. Small-Mid Growth Comp 3.64

Siren, L.L.C. 3.34

Baker Bros Advisors LP 2.63

MPM Oncology Impact Management LP 1.89

Yiheng Capital LLC 1.18

Millennium Management LLC 1.15

Octagon Capital Advisors LP 1.03

Schonfeld Strategic Advisors LLC 0.82

Great Point Partners LLC 0.68

Patient Square Capital LP 0.65

Vestal Point Capital LP 0.54

Squadron Capital Management LLC 0.43

Balyasny Asset Management LLC 0.42

New York State Common Retirement Fund 0.40

Atika Capital Management LLC 0.37

BOOTHBAY FUND MANAGEMENT, LLC 0.29

Citadel Advisors Llc 0.26

Artisan International Small-Mid Tr Fdrs 0.12

Polymer Capital Management (Hk) Ltd 0.12

AdvisorShares Dorsey Wright ADR ETF 0.10

Optiver Holding B.V. 0.09

Dorsey Wright Sys Reltv Strength Intl 0.03

Russell Inv Tax-Managed US Mid&Sm Cap S 0.03

Russell Inv US Small Cap Equity Y 0.02

Russell Inv Small Cap Fund F 0.01

Fidelity Nasdaq Composite Index 0.01

Russell Inv Equity II 0.01

Russell Inv US Small Cap Equity 0.00

Gabelli Health & Wellness 0.00

ST Dorsey Wright® Intl Momntm Tr 39 CA 0.00

ST Dorsey Wright® Intl Momntm Tr 42 CA 0.00

HJIM International Select Small Cap 0.00

DBV Technologies S.A. - Spons-ADR Market Status

Strong Buy: 0

Buy: 2

Hold: 0

Sell: 1

Strong Sell: 0

DBV Technologies S.A. - Spons-ADR Fundamentals

Market Cap 1071.39 M

PB Ratio 20.1033

PE Ratio 0.0

Enterprise Value 1023.40 M

Total Assets 65.66 M

Volume 294496

DBV Technologies S.A. - Spons-ADR Company Financials

Annual Revenue FY23:0 0.0M, FY22:4800000 4.8M, FY21:5708000 5.7M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:4800000 4.8M, FY21:5708000 5.7M, FY20:null 0.0M, FY19:-144983000 -145.0M

Annual Net worth FY23:-100781000 -100.8M, FY22:-96300000 -96.3M, FY21:-97809000 -97.8M, FY20:-159559000 -159.6M, FY19:-172042746 -172.0M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:511000 0.5M, Q3/2024:0 0.0M, Q2/2024:1161000 1.2M

Quarterly Profit Q3/2025:-4281868 -4.3M, Q2/2025:-4619486 -4.6M, Q1/2025:-4477344 -4.5M, Q3/2024:null 0.0M, Q2/2024:1161000 1.2M

Quarterly Net worth Q3/2025:-33016481 -33.0M, Q2/2025:-42402674 -42.4M, Q1/2025:-27099244 -27.1M, Q3/2024:-30442000 -30.4M, Q2/2024:-33116000 -33.1M

About DBV Technologies S.A. - Spons-ADR & investment objective

Company Information DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. The company's product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow's milk protein allergy and eosinophilic esophagitis. Its earlier stage research programs include vaccine for the respiratory syncytial virus, potential treatments for inflammatory bowel disease, celiac disease, and type I diabetes. In addition, the company develops Viaskin technology platform, a platform to potentially treat food allergy. It has a collaboration with Nestlé Health Science to develop MAG1C, a ready-to-use atopy patch test for the diagnosis of non-IgE mediated CMPA in infants and toddlers. DBV Technologies S.A. was incorporated in 2002 and is headquartered in Châtillon, France.

Organisation Biotechnology

Employees 117

Industry Biotechnology

CEO Mr. Daniel Tassé

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

DBV Technologies S.A. - Spons-ADR FAQs

What is the share price of DBV Technologies S.A. - Spons-ADR today?

The current share price of DBV Technologies S.A. - Spons-ADR is $19.

Can I buy DBV Technologies S.A. - Spons-ADR shares in India?

Yes, Indian investors can buy DBV Technologies S.A. - Spons-ADR shares by opening an international trading and demat account with Motilal Oswal.

How to buy DBV Technologies S.A. - Spons-ADR shares in India?

You can easily invest in DBV Technologies S.A. - Spons-ADR shares from India by:

Can I buy fractional shares of DBV Technologies S.A. - Spons-ADR?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of DBV Technologies S.A. - Spons-ADR?

DBV Technologies S.A. - Spons-ADR has a market cap of $1071.39 M.

In which sector does DBV Technologies S.A. - Spons-ADR belong?

DBV Technologies S.A. - Spons-ADR operates in the Biotechnology sector.

What documents are required to invest in DBV Technologies S.A. - Spons-ADR stocks?

To invest, you typically need:

What is the PE and PB ratio of DBV Technologies S.A. - Spons-ADR?

The PE ratio of DBV Technologies S.A. - Spons-ADR is N/A and the PB ratio is 20.10.